Cargando…
Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion
INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550874/ https://www.ncbi.nlm.nih.gov/pubmed/16646985 http://dx.doi.org/10.1186/cc4903 |
_version_ | 1782129293427474432 |
---|---|
author | Ricci, Zaccaria Ronco, Claudio Bachetoni, Alessandra D'amico, Giuseppe Rossi, Stefano Alessandri, Elisa Rocco, Monica Pietropaoli, Paolo |
author_facet | Ricci, Zaccaria Ronco, Claudio Bachetoni, Alessandra D'amico, Giuseppe Rossi, Stefano Alessandri, Elisa Rocco, Monica Pietropaoli, Paolo |
author_sort | Ricci, Zaccaria |
collection | PubMed |
description | INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically ill patients, comparing small (urea and creatinine) and middle (β(2 )microglobulin) molecular weight solute clearance, filter lifespan and membrane performance over a period of 72 hours, during 15 continuous veno-venous dialysis (CVVHD) and 15 continuous veno-venous hemofiltration (CVVH)sessions. Both modalities were administered based on a prescription of 35 ml/kg/h and using polyacrylonitrile filters. RESULTS: Median filter lifespan was significantly longer during CVVHD (37 hours, interquartile range (IQR) 19.5 to 72.5) than CVVH (19 hours, IQR 12.5 to 28) (p = 0.03). Median urea time weighted average (TWA) clearances were not significantly different during CVVH (31.6 ml/minute, IQR 23.2 to 38.9) and CVVHD (35.7 ml/minute, IQR 30.1 to 41.5) (p = 0.213). Similar results were found for creatinine: 38.1 ml/minute, IQR 28.5 to 39, and 35.6 ml/minute, IQR 26 to 43 (p = 0.917), respectively. Median β(2)m TWA clearance was higher during convective (16.3 ml/minute, IQR 10.9 to 23) than diffusive (6.27 ml/minute, IQR 1.6 to 14.9) therapy; nonetheless this difference did not reach statistical significance (p = 0.055). Median TWA adsorptive clearance of β(2)m appeared to have scarce impact on overall solute removal (0.012 ml/minute, IQR -0.09 to 0.1, during hemofiltration versus -0.016 ml/minute, IQR -0.08 to 0.1 during dialysis; p = 0.79). Analysis of clearance modification over time did not show significant modifications of urea, creatinine and β(2)m clearance in the first 48 hours during both treatments. In the CVVHD group, the only significant difference was found for β(2)m between 72 hours and baseline clearance. CONCLUSION: Polyacrylonitrile filters during continuous hemofiltration and continuous hemodialysis delivered at 35 ml/kg/h are comparable in little and middle size solute removal. CVVHD appears to warrant longer CRRT sessions. The capacity of both modalities for removing such molecules is maintained up to 48 hours. |
format | Text |
id | pubmed-1550874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-15508742006-08-22 Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion Ricci, Zaccaria Ronco, Claudio Bachetoni, Alessandra D'amico, Giuseppe Rossi, Stefano Alessandri, Elisa Rocco, Monica Pietropaoli, Paolo Crit Care Research INTRODUCTION: The best modality, for continuous renal replacement therapy (CRRT) is currently uncertain and it is poorly understood how transport of different solutes, whether convective or diffusive, changes over time. METHODS: We conducted a prospective cross over study in a cohort of critically ill patients, comparing small (urea and creatinine) and middle (β(2 )microglobulin) molecular weight solute clearance, filter lifespan and membrane performance over a period of 72 hours, during 15 continuous veno-venous dialysis (CVVHD) and 15 continuous veno-venous hemofiltration (CVVH)sessions. Both modalities were administered based on a prescription of 35 ml/kg/h and using polyacrylonitrile filters. RESULTS: Median filter lifespan was significantly longer during CVVHD (37 hours, interquartile range (IQR) 19.5 to 72.5) than CVVH (19 hours, IQR 12.5 to 28) (p = 0.03). Median urea time weighted average (TWA) clearances were not significantly different during CVVH (31.6 ml/minute, IQR 23.2 to 38.9) and CVVHD (35.7 ml/minute, IQR 30.1 to 41.5) (p = 0.213). Similar results were found for creatinine: 38.1 ml/minute, IQR 28.5 to 39, and 35.6 ml/minute, IQR 26 to 43 (p = 0.917), respectively. Median β(2)m TWA clearance was higher during convective (16.3 ml/minute, IQR 10.9 to 23) than diffusive (6.27 ml/minute, IQR 1.6 to 14.9) therapy; nonetheless this difference did not reach statistical significance (p = 0.055). Median TWA adsorptive clearance of β(2)m appeared to have scarce impact on overall solute removal (0.012 ml/minute, IQR -0.09 to 0.1, during hemofiltration versus -0.016 ml/minute, IQR -0.08 to 0.1 during dialysis; p = 0.79). Analysis of clearance modification over time did not show significant modifications of urea, creatinine and β(2)m clearance in the first 48 hours during both treatments. In the CVVHD group, the only significant difference was found for β(2)m between 72 hours and baseline clearance. CONCLUSION: Polyacrylonitrile filters during continuous hemofiltration and continuous hemodialysis delivered at 35 ml/kg/h are comparable in little and middle size solute removal. CVVHD appears to warrant longer CRRT sessions. The capacity of both modalities for removing such molecules is maintained up to 48 hours. BioMed Central 2006 2006-04-28 /pmc/articles/PMC1550874/ /pubmed/16646985 http://dx.doi.org/10.1186/cc4903 Text en Copyright © 2006 Ricci et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Ricci, Zaccaria Ronco, Claudio Bachetoni, Alessandra D'amico, Giuseppe Rossi, Stefano Alessandri, Elisa Rocco, Monica Pietropaoli, Paolo Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title | Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title_full | Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title_fullStr | Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title_full_unstemmed | Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title_short | Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
title_sort | solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550874/ https://www.ncbi.nlm.nih.gov/pubmed/16646985 http://dx.doi.org/10.1186/cc4903 |
work_keys_str_mv | AT riccizaccaria soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT roncoclaudio soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT bachetonialessandra soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT damicogiuseppe soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT rossistefano soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT alessandrielisa soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT roccomonica soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion AT pietropaolipaolo soluteremovalduringcontinuousrenalreplacementtherapyincriticallyillpatientsconvectionversusdiffusion |